|
MORC3 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.223300E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.836200E-02 |
| Normal-vs-Stage2 |
6.402400E-04 |
| Normal-vs-Stage3 |
3.922700E-03 |
| Normal-vs-Stage4 |
3.520900E-03 |
| Stage1-vs-Stage2 |
3.457700E-02 |
| Stage1-vs-Stage3 |
1.791550E-01 |
| Stage1-vs-Stage4 |
1.645410E-01 |
| Stage2-vs-Stage3 |
2.835600E-01 |
| Stage2-vs-Stage4 |
3.666400E-01 |
| Stage3-vs-Stage4 |
8.966800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.301790E-02 |
| Normal-vs-AfricanAmerican |
3.902000E-01 |
| Normal-vs-Asian |
7.298300E-02 |
| Caucasian-vs-AfricanAmerican |
4.063000E-01 |
| Caucasian-vs-Asian |
7.887200E-01 |
| AfricanAmerican-vs-Asian |
5.733400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.205000E-04 |
| Normal-vs-Female |
2.022500E-02 |
| Male-vs-Female |
1.680620E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.479800E-01 |
| Normal-vs-Age(41-60Yrs) |
6.216700E-03 |
| Normal-vs-Age(61-80Yrs) |
3.197500E-04 |
| Normal-vs-Age(81-100Yrs) |
3.881900E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.482400E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.122300E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.372000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.920420E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.106800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.589600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.924400E-01 |
| Classical-VS-Follicular |
3.53949999976066E-07 |
| Classical-VS-Other |
2.723800E-01 |
| Classical-VS-Normal |
1.570610E-01 |
| Tall-VS-Follicular |
4.460100E-02 |
| Tall-VS-Other |
5.744200E-01 |
| Tall-VS-Normal |
4.869900E-02 |
| Follicular-VS-Other |
5.799600E-01 |
| Follicular-VS-Normal |
2.00679999995401E-06 |
| Other-VS-Normal |
9.080200E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.751900E-04 |
| Normal-vs-N1 |
9.380300E-03 |
| N0-vs-N1 |
5.732600E-01 |
|
|
